Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature
Deepak Balak, Sascha Gerdes, Aurora Parodi, et al.
Dermatology and Therapy (2020) Vol. 10, Iss. 4, pp. 589-613
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults
Zhijie Ruan, Tao Lu, Yanxia Chen, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 7, pp. 745-745
Open Access | Times Cited: 142
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
April W. Armstrong, Kyle Fahrbach, Craig L. Leonardi, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1777-1792
Open Access | Times Cited: 41
Microneedle-assisted percutaneous delivery of methotrexate-loaded nanoparticles enabling sustained anti-inflammatory effects in psoriasis therapy
Hongyao Du, Jing Yang, Mo Li, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 10, pp. 2618-2627
Closed Access | Times Cited: 13
Deucravacitinib in the treatment of psoriasis
Tomás Estevinho, Ana Maria Lé, Tiago Torres
Journal of Dermatological Treatment (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 24
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
Diego Orsini, Luigi Gargiulo, Luciano Ibba, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 15
Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases
Luxia Chen, Lei Xuan, Karsten Mahnke
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5810-5810
Open Access | Times Cited: 5
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
Deepak Balak, Stefano Piaserico, Ismail Kasujee
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 151-168
Open Access | Times Cited: 30
Sonodynamic therapy by phase-transition nanodroplets for reducing epidermal hyperplasia in psoriasis
Long Fu Xi, Yunfeng Han, Chang Liu, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 435-447
Closed Access | Times Cited: 20
Pharmacology of orismilast, a potent and selective PDE4 inhibitor
Jonathan I. Silverberg, Lars E. French, Richard B. Warren, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 4, pp. 721-729
Open Access | Times Cited: 20
Photothermal treatment by PLGA–gold nanorod–isatin nanocomplexes under near-infrared irradiation for alleviating psoriasiform hyperproliferation
G.R. Nirmal, Zih‐Chan Lin, Ming‐Jun Tsai, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 487-499
Closed Access | Times Cited: 25
The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials
Liuting Zeng, Ganpeng Yu, Yang Wu, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 24
Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016
Yidian Fu, Chao Jiang, Zonglin Li, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion
Boni E. Elewski, Mark Lebwohl
Journal of Psoriasis and Psoriatic Arthritis (2025)
Open Access
Targeting IL‐23 with Small Molecule Inhibitors: A New Horizon In Psoriasis Therapy
Raghad Sharbaji, Pınar Si̇yah
ChemistrySelect (2025) Vol. 10, Iss. 8
Closed Access
Polyphenol Microneedles for Dermatological Therapy
Chunlei Liu, Jinhui Ran, Xie Zhi-ping, et al.
Macromolecular Bioscience (2025)
Closed Access
High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Kave Shams, Jennifer Montgomery, J. E. Morley, et al.
Dermatology and Therapy (2025)
Open Access
Janus double-sided nanofibrous patch with asymmetric wettability and controlled topical delivery of tryptanthrin and indirubin as an effective therapy for psoriasis
Ruodan Xu, Pengyu Wang, Can Cao, et al.
Materials Today Bio (2025), pp. 101822-101822
Open Access
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life
Matthias Augustin, Juliet N. Barker, Curdin Conrad, et al.
Dermatology and Therapy (2025)
Open Access
PDE4 inhibitors in psoriasis therapy: current insights and future directions
Amit Sharma, Niyati Pandoh, Keerti Dayal, et al.
Inflammopharmacology (2025)
Closed Access
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies
Salvatore Crisafulli, Lucrezia Bertino, Andrea Fontana, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim Papp, Barbara Melosky, Sandeep Sehdev, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 867-889
Open Access | Times Cited: 8
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV
Tomás Estevinho, Egídio Freitas, Tiago Torres
Journal of International Medical Research (2024) Vol. 52, Iss. 3
Open Access | Times Cited: 3
A Route for Investigating Psoriasis: From the Perspective of the Pathological Mechanisms and Therapeutic Strategies of Cancer
Xingkang Wu, Yushuang Ma, Lu Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14390-14390
Open Access | Times Cited: 7
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Advances in Therapy (2024) Vol. 41, Iss. 10, pp. 3778-3791
Closed Access | Times Cited: 2
Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin
Anna Andrea Lauer, Daniel Janitschke, Malena dos Santos Guilherme, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top